IL22 and graft versus host disease: In conclusion, our analysis of intestinal biopsies from allogenic SCT patients further highlights the outstanding importance of IL-22 on the clinical outcome after allogeneic SCT and strengthens the therapeutic potential of IL-22 for the amelioration of GvHD associated complications.